会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • ANCHORED LIGAND AGENTS
    • 安装的配对代理
    • WO2008134069A3
    • 2009-02-12
    • PCT/US2008005528
    • 2008-04-28
    • UNIV FLORIDATAN WEIHONGCAO ZEHUIKIM YOUNGMI
    • TAN WEIHONGCAO ZEHUIKIM YOUNGMI
    • C12Q1/68
    • C12N15/115C12N2310/16C12N2310/351C12N2320/50
    • The invention provides novel therapeutic agents comprising ligand molecules such as aptamers linked to a molecular anchor (MA). In the absence of a MA, ligands rapidly diffuse into bulk solution after dissociation from a target molecule. With a MA tightly bound to the target molecule, anchored ligand molecules of the invention remain in close proximity to the active site on the target molecule, even after dissociating from the target, permitting rapid re- binding of ligand to its target. Reversibility of binding to the active site can be effectively and rapidly achieved using antidotes based on the complementary DNA sequences. A preferred embodiment in accordance with the invention is a highly efficient anticoagulant agent that demonstrates binding efficiency to thrombin that is increased many fold relative to a corresponding unanchored aptamer-based ligand.
    • 本发明提供了包含配体分子的新型治疗剂,例如与分子锚(MA)连接的适体。 在不存在MA的情况下,配体在从靶分子解离后迅速扩散到本体溶液中。 使用与目标分子紧密结合的MA,本发明的锚定配体分子即使在与靶分离之后也保持紧邻目标分子上的活性位点,从而允许配体与靶标快速重结合。 使用基于互补DNA序列的解毒剂可以有效快速地实现与活性位点结合的可逆性。 根据本发明的优选实施方案是高效抗凝剂,其显示出相对于相应的未锚定的适体基配体增加多倍的凝血酶的结合效率。
    • 3. 发明申请
    • LIQUEFACTION BIOMASS PROCESSING WITH HEAT RECOVERY
    • 采用热回收的液化生物质处理
    • WO2012016180A3
    • 2012-06-07
    • PCT/US2011045958
    • 2011-07-29
    • PURDUE RESEARCH FOUNDATIONLADISCH MICHAEL RMOSIER NATHANKIM YOUNGMIROOYEN JUSTIN VAN
    • LADISCH MICHAEL RMOSIER NATHANKIM YOUNGMIROOYEN JUSTIN VAN
    • C12P7/06C12P7/10
    • C08B1/00C12N1/22C12P7/10C12P19/02C12P19/14Y02E50/16Y02E50/17Y02P20/124Y02P20/59
    • Described are processes that include the non-enzymatic, hydrolytic liquefaction of lignocellulosic biomass to form digest slurries and heat recovery from such digest slurries. Due to enhanced flow properties of the digest slurries such heat recovery can be efficiently conducted in spiral, plate and frame or other heat exchanger designs, with the recovered heat going to unit operations of the process such as heating incoming pretreatment media for the liquefaction. Processes can also involve additional hydrolytic digestion of some or all of the initial slurry components with enzyme and/or additional heat recovery from the initial slurry by direct contact heat exchange in which a portion of the digest slurry liquids is flashed to vapor and that vapor is condensed onto incoming lignocellulosic biomass to the process. Processes as described can be integrated into ethanol manufacture by fermentation of sugars from the digested compositions.
    • 描述了包括木质纤维素生物质的非酶促水解液化以形成消化浆料并从这些消化浆料中热回收的方法。 由于消化浆料的流动性能的提高,这种热回收可以在螺旋,板和框架或其它热交换器设计中有效地进行,回收的热量将进行到工艺的单元操作,例如加热输入的用于液化的预处理介质。 方法还可以通过直接接触热交换使酶的一些或所有初始浆料组分进一步水解消化,和/或从初始浆料进一步热回收,其中将一部分消化浆料液体闪蒸至蒸气,蒸气为 浓缩到进入的木质纤维素生物质上。 所描述的方法可以通过从消化的组合物中发酵糖而被整合到乙醇生产中。
    • 4. 发明申请
    • NOVEL BIOLOGICAL DETECTION METHOD FOR DIOXINS IN SERUM, AND A DIAGNOSTIC USE THEREFOR IN METABOLIC SYNDROME AND RELATED CONDITIONS
    • 血清中二氧化物的新生物检测方法及其代谢综合征及相关情况的诊断用途
    • WO2012033324A3
    • 2012-06-14
    • PCT/KR2011006583
    • 2011-09-06
    • UNIV KYUNG HEE UNIV IND COOP GROUPLEE HONG KYUKIM YOUNGMI
    • LEE HONG KYUKIM YOUNGMI
    • C12Q1/68C12N15/85C12Q1/66
    • C12Q1/6897C12Q1/66G01N33/5308G01N2800/04
    • The present invention relates to a novel biological detection method for dioxins in serum, and to a diagnostic use therefor in metabolic syndrome and related conditions. More specifically, by measuring luciferase activity through the use of serum as a whole and cells that have been genetically transformed by means of a recombinant vector comprising a gene construct in which a dioxin response element (dioxin-responsive element), a promoter and a reporter gene have been operably linked, a significant correlation has been confirmed between physical variables and the content of dioxins in serum, and there is an improvement over existing methods which require a pre-processing step in order to purify dioxins from the blood, and a plurality of samples can be analysed both easily and accurately even in very small amounts because of the use of serum as a whole, and hence the detection system of the present invention, which involves total serum processing in a genetically transformed cell line comprising a recombinant reporter gene whose expression is modified by dioxin compounds, can be used to advantage in the biological detection of dioxins within serum, and this method can be used to research the correlation between specific POPs and patients' diseases by accurately detecting whether POPs such as dioxins are present in the serum, and this can be used to advantage in predicting the occurrence of diseases and determining treatability.
    • 本发明涉及血清中二恶英的新型生物检测方法及其代谢综合征及相关病症的诊断用途。 更具体地,通过使用血清作为整体测量荧光素酶活性,以及​​通过包含二恶英应答元件(二恶英应答元件),启动子和报告基因的基因构建体的重组载体进行遗传转化的细胞 基因已经可操作地连接,物理变量和血清中二恶英含量之间已经证实了显着的相关性,并且对于需要预处理步骤以从血液中纯化二恶英的现有方法有改进,并且多个 由于使用血清作为整体,因此可以容易且精确地分析样品,因此本发明的检测系统涉及在包含重组报告基因的遗传转化细胞系中的总血清加工 其表达被二恶英化合物修饰,可用于生物检测血清中二恶英的有效性 该方法可用于通过准确检测血清中是否存在二恶英类POPs来研究特异性POPs与患者疾病之间的相关性,可用于预测疾病的发生和确定可治疗性。